Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis

Expert Opinion on Therapeutic Targets
Mario Nuvolone, G Merlini

Abstract

Systemic amyloidosis occurs when one of a growing list of circulating proteins acquires an abnormal fold, aggregates and gives rise to extracellular amyloid deposits in different body sites, leading to organ dysfunction and eventually death. Current approaches are mainly aimed at lowering the supply of the amyloidogenic precursor or at stabilizing it in a non-amyloidogenic state, thus interfering with the initial phases of amyloid formation and toxicity. Areas covered: Improved understanding of the pathophysiology is indicating novel steps and molecules that could be therapeutically targeted. Here, we will review emerging molecular targets and therapeutic approaches against the main forms of systemic amyloidosis at the early preclinical level. Expert opinion: Conspicuous efforts in drug design and drug discovery have provided an unprecedented list of potential new drugs or therapeutic strategies, from gene-based therapies to small molecules and peptides, from novel monoclonal antibodies to engineered cell-based therapies. The challenge will now be to validate and optimize the most promising candidates, cross the bridge from the preclinical phase to the clinics and identify, through innovative trials design, the safest and most ...Continue Reading

References

Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P WestermarkG G Cornwell
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·G MerliniP Garini
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·V EpiskopouE J Robertson
Aug 5, 2000·Biochemical and Biophysical Research Communications·M YazakiS Ikeda
Sep 29, 2001·Science·P HammarströmJ W Kelly
Aug 9, 2003·The New England Journal of Medicine·Giampaolo Merlini, Vittorio Bellotti
Oct 30, 2003·Journal of the American Chemical Society·Nora S GreenJeffery W Kelly
Jan 17, 2004·The Journal of Biological Chemistry·Stephanie PlanqueSudhir Paul
Feb 13, 2004·Gene Therapy·M NakamuraK Yamamura
Dec 17, 2005·Laboratory Investigation; a Journal of Technical Methods and Pathology·Hisayasu TerazakiMaria J Saraiva
Jan 18, 2006·Annual Review of Medicine·Mark B Pepys
May 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Brian O'NuallainAlan Solomon
Jun 24, 2006·Blood·Giampaolo Merlini, Marvin J Stone
Mar 24, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·A Myron JohnsonUNKNOWN Scientific Division Committee on Plasma Proteins (C-PP), International Federation of Clinical Chemistry and Laboratory Medic
Apr 24, 2007·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Emanuele PilatoGiorgio Arpesella
Apr 3, 2008·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Ayako TsuchiyaShu-ichi Ikeda
May 31, 2008·Nature Structural & Molecular Biology·Dagmar E EhrnhoeferErich E Wanker
Feb 13, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jianru ShiRonglih Liao
Jul 20, 2010·Experimental Hematology·Jonathan E PhippsJonathan S Wall
Jul 28, 2010·Neurology·Juris J LiepnieksMerrill D Benson
Aug 10, 2010·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Bárbara MacedoMaria João Saraiva
Nov 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Simon E KolstoeMark B Pepys
Nov 26, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Elisabet IhsePer Westermark
May 13, 2011·Gene Therapy·B M HoveyD C Seldin
Aug 16, 2011·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·C SiracM Cogné
Aug 16, 2011·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·L LobatoR Almeida
Aug 26, 2011·Science Translational Medicine·Mamoun M AlhamadshehIsabella A Graef
Sep 16, 2011·Journal of the American Chemical Society·Sharmistha SinhaGal Bitan
May 4, 2012·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Laura ObiciGiampaolo Merlini
Apr 30, 2013·American Journal of Physiology. Heart and Circulatory Physiology·Shikha MishraRonglih Liao
May 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Sravan C PenchalaMamoun M Alhamadsheh
Aug 30, 2013·The New England Journal of Medicine·Teresa CoelhoOle B Suhr
Oct 23, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Taxiarchis V KourelisAngela Dispenzieri
Dec 26, 2013·JAMA : the Journal of the American Medical Association·John L BerkUNKNOWN Diflunisal Trial Consortium
Jan 25, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Nelson FerreiraMaria Rosário Almeida
Feb 4, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Inmaculada Conejos-SánchezMaría J Vicent

❮ Previous
Next ❯

Citations

Feb 26, 2019·The Journal of International Medical Research·Guoliang LiLimei Chen
Jul 26, 2019·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Filipa BezerraMaria Rosário Almeida
Sep 6, 2019·Hematological Oncology·Rahel SchwotzerBernhard Gerber
Nov 16, 2019·Cellular and Molecular Life Sciences : CMLS·Ridwan Babatunde IbrahimYo-Tsen Liu
Feb 14, 2020·Transplantation·Avital Angel-Korman, Andrea Havasi
Apr 20, 2019·Frontiers in Physiology·Ridwan Babatunde IbrahimJin-Wu Tsai
Jul 30, 2020·Expert Review of Hematology·Marco BassetGiampaolo Merlini
Aug 6, 2020·Frontiers in Pharmacology·Alice NevoneMario Nuvolone
Jun 29, 2018·Current Hematologic Malignancy Reports·Nisha S Joseph, Jonathan L Kaufman
Dec 15, 2020·Modern Rheumatology Case Reports·Reina TsudaKazuyuki Tobe
May 1, 2021·Journal of Clinical Medicine·Rupali S AvasareJonathan J Hogan

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

The Netherlands Journal of Medicine
G Merlini
Current Opinion in Pharmacology
Helen J Lachmann, Philip N Hawkins
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Mario Nuvolone, G Merlini
Annals of Clinical Biochemistry
Jennifer H Pinney, Philip N Hawkins
© 2022 Meta ULC. All rights reserved